Cost-effectiveness analysis of endoscopic eradication therapy for treatment of high-grade dysplasia in Barrett's esophagus [PDF]
, 2017 AIM: The aim was to evaluate the cost-effectiveness of endoscopic eradication therapy (EET) with combined endoscopic mucosal resection and radiofrequency ablation for the treatment of high-grade dysplasia (HGD) arising in patients with Barrett's ...
Filby, A +4 more
core +1 more source
DEN Open, Volume 6, Issue 1, April 2026.This meta‐analysis of nine studies (202 patients) demonstrates that peroral endoscopic myotomy with fundoplication (POEM‐F) achieves a technical success of 94.8% and significant symptom improvement (Eckardt score reduction from 8.3 to 1.1). Post‐procedural esophagitis occurred in 20.7% and wrap integrity was preserved in 75.7% on follow‐up, supporting ...
Yusuf Kagzi +2 more
wiley +1 more source
Multilayered Epithelium in a Rat Model and Human Barrett's Esophagus: Similar Expression Patterns of Transcription Factors and Differentiation Markers [PDF]
, 2012 Background: In rats, esophagogastroduodenal anastomosis (EGDA) without concomitant chemical carcinogen treatment leads to gastroesophageal reflux disease, multilayered epithelium (MLE, a presumed precursor in intestinal metaplasia), columnar-lined ...
Chen, Xiaoxin +8 more
core +1 more source
Endoscopy International Open, 2016 Background and study aims: Barrett’s esophagus is a common condition that is widely encountered in clinical practice. This European Society of Gastrointestinal Endoscopy (ESGE) survey aimed to determine practice patterns amongst European clinicians with ...
Simon J. Dunn +5 more
doaj +1 more source
microRNAs and Esophageal Cancer - Implications for Pathogenesis and Therapy [PDF]
, 2013 Author version made available in accordance with the publisher's policy.There are several microRNAs that have been consistently reported to be differentially expressed in esophageal squamous cell carcinoma vs.
Hussey, Damian James +2 more
core
Mo1246 CLINICAL APPLICABILITY OF WIDE AREA TRANSEPITHELIAL SAMPLING (WATS-3D) IN SCREENING & SURVEILLANCE OF BARRETT'S ESOPHAGUS - A SYSTEMATIC REVIEW & SENSITIVITY META-ANALYSIS [PDF]
, 2020 Saurabh Chandan +9 more
openalex +1 more source
Patient‐Reported‐Outcome‐Measures (PROMs) After Gastrointestinal Endoscopic Resections
United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.ABSTRACT Background Data on patient‐reported outcome measures (PROMs) of patients undergoing endoscopic resections have been sparse. The aim of our study was the prospective assessment of the Gastrointestinal Quality of Life Index (GIQLI) as a baseline and post‐endoscopic resection (ER) measurement in patients with epithelial mucosal neoplasms ...
Laura Retzbach +4 more
wiley +1 more source
Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma [PDF]
, 2016 Clinically useful marker molecules for the progression of gastroesophageal reflux disease and Barrett's esophagus (BE) to esophageal adenocarcinoma (EAC) are lacking. Many adenocarcinomas and inflammatory conditions exhibit increased expression of ADAMs,
Ilonen, I. +7 more
core +1 more source
Clinical Obesity, Volume 16, Issue 1, February 2026.ABSTRACT Body mass index (BMI) on its own is a poor diagnostic and staging tool for obesity because it does not measure health status. The newly published Lancet Clinical Obesity Criteria (LCOC) for defining clinical obesity distinguish preclinical and clinical obesity based on organ or tissue dysfunction.
Tak Ying Louise Ko +3 more
wiley +1 more source